Biphasic Peritoneal Mesothelioma: A Lethal Clinical Entity
- PMID: 35371775
- PMCID: PMC8960911
- DOI: 10.7759/cureus.22638
Biphasic Peritoneal Mesothelioma: A Lethal Clinical Entity
Erratum in
-
Correction: Biphasic Peritoneal Mesothelioma: A Lethal Clinical Entity.Cureus. 2023 May 30;15(5):c120. doi: 10.7759/cureus.c120. eCollection 2023 May. Cureus. 2023. PMID: 37265893 Free PMC article.
Abstract
Mesotheliomas are a rare malignancy of the serosal membrane. Mainly it affects the pleural surfaces followed by the second most common location, "peritoneum." The disease follows an aggressive pattern of spread, and by the time the diagnosis is established, the condition significantly spreads to distant locations. Diagnosis of malignant peritoneal mesothelioma is typically made by tissue biopsy. The standard treatment is radical resection; however, patients have benefited from several other modalities. The current case report describes a unique case of malignant mesothelioma, biphasic peritoneal mesothelioma (BPM), which comprises less than 25% of all peritoneal mesotheliomas. The diagnosis and treatment do not differ from other subtypes; however, the prognosis is poor, and if untreated, the survival is typically less than six months.
Keywords: abdominal; biphasic; mesotheliomas; neoplasms; peritoneal.
Copyright © 2022, Waheed et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures



Similar articles
-
Localized multiple malignant epithelioid peritoneal mesotheliomas arising from the hepatoduodenal ligament and diaphragm: a case report.J Med Case Rep. 2019 Mar 18;13(1):66. doi: 10.1186/s13256-019-2008-9. J Med Case Rep. 2019. PMID: 30879467 Free PMC article.
-
Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study.Neoplasma. 2014;61(2):161-9. doi: 10.4149/neo_2014_031. Neoplasma. 2014. PMID: 24471939
-
[Medical insurance aspects of peritoneal tumors with particular attention to peritoneal mesotheliomas].Med Klin (Munich). 2009 Oct 15;104(10):765-71. doi: 10.1007/s00063-009-1162-z. Epub 2009 Oct 25. Med Klin (Munich). 2009. PMID: 19856150 Review. German.
-
Epidemiology and outcome of peritoneal and pleural mesothelioma subtypes in Norway. A 20 year nation-wide study.Acta Oncol. 2021 Oct;60(10):1250-1256. doi: 10.1080/0284186X.2021.1955971. Epub 2021 Jul 27. Acta Oncol. 2021. PMID: 34313510
-
[Peritoneal malignant mesothelioma: review and recent data].Ann Pathol. 2014 Feb;34(1):26-33. doi: 10.1016/j.annpat.2014.01.004. Epub 2014 Feb 11. Ann Pathol. 2014. PMID: 24630634 Review. French.
Cited by
-
Biphasic Peritoneal Mesothelioma Is a Rare Tumor and a Diagnostic Challenge: A Case Report.Cureus. 2024 Jan 5;16(1):e51725. doi: 10.7759/cureus.51725. eCollection 2024 Jan. Cureus. 2024. PMID: 38318560 Free PMC article.
References
-
- Epidemiology and outcome of peritoneal and pleural mesothelioma subtypes in Norway. A 20 year nation-wide study. Brustugun OT, Nilssen Y, Eide IJ. Acta Oncol. 2021;60:1250–1256. - PubMed
-
- Malignant peritoneal mesothelioma: correlation between CT imaging features and histologic subtypes. Atre ID, Watane GV, Harisinghani MG. Abdom Radiol (NY) 2021;46:5105–5113. - PubMed
-
- Malignant peritoneal mesothelioma -- diagnostic and therapeutic difficulties (Article in Portuguese) Cunha P, Luz Z, Sees I, et al. https://actamedicaportuguesa.com/revista/index.php/amp/article/view/1970. Acta Med Port. 2002;15:383–386. - PubMed
-
- Peritoneal mesothelioma. Raptopoulos V. https://pubmed.ncbi.nlm.nih.gov/3896651/ Crit Rev Diagn Imaging. 1985;24:293–328. - PubMed
-
- Peritoneal mesothelioma: a review. Bridda A, Padoan I, Mencarelli R, Frego M. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994863/ MedGenMed. 2007;9:32. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources